Publications in collaboration with researchers from Hospital General San Jorge (9)

2019

  1. Objectives and methodology of BIOBADASER phase III

    Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640

2010

  1. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1751-1755

2008

  1. Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas

    Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20

2006

  1. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1

2004

  1. Prevelance and associated factors of anterior atlantoaxial luxation in a nation-wide sample of rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 4, pp. 427-432

2003

  1. Patterns of disease modifing antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 30, Núm. 4, pp. 697-704